Federated Hermes’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$276K Sell
61,350
-297,557
-83% -$1.19M ﹤0.01% 1438
2025
Q4
$1.37M Buy
358,907
+356,512
+14,886% +$1.39M ﹤0.01% 1043
2025
Q3
$7.74K Sell
2,395
-260
-10% -$975 ﹤0.01% 1904
2025
Q2
$7.67K Buy
+2,655
New +$6.15K ﹤0.01% 1850
2024
Q4
Sell
-3
Closed -$20 2146
2024
Q3
$20 Buy
3
+2
+200% +$16 ﹤0.01% 2037
2024
Q2
$7 Buy
+1
New +$8 ﹤0.01% 2008
2020
Q2
Sell
-2
Closed -$1K 2317
2020
Q1
$1K Sell
2
-2
-50% -$26 ﹤0.01% 2122
2019
Q4
$1K Hold
4
﹤0.01% 2114
2019
Q3
$1K Sell
4
-5
-56% -$55 ﹤0.01% 2114
2019
Q2
$1K Sell
9
-39
-81% -$1.04K ﹤0.01% 2115
2019
Q1
$2K Sell
48
-159
-77% -$8.15K ﹤0.01% 2068
2018
Q4
$12K Sell
207
-37
-15% -$3.65K ﹤0.01% 1849
2018
Q3
$34K Sell
244
-3
-1% -$364 ﹤0.01% 1786
2018
Q2
$30K Sell
247
-3,931
-94% -$334K ﹤0.01% 1751
2018
Q1
$373K Sell
4,178
-3,020
-42% -$256K ﹤0.01% 1434
2017
Q4
$399K Sell
7,198
-245
-3% -$11K ﹤0.01% 1415
2017
Q3
$314K Sell
7,443
-3,326
-31% -$138K ﹤0.01% 1437
2017
Q2
$454K Buy
10,769
+3
+0% +$153 ﹤0.01% 1400
2017
Q1
$602K Sell
10,766
-39
-0.4% -$1.94K ﹤0.01% 1294
2016
Q4
$412K Buy
10,805
+2,294
+27% +$93K ﹤0.01% 1365
2016
Q3
$338K Buy
8,511
+1,446
+20% +$65.7K ﹤0.01% 1384
2016
Q2
$508K Buy
7,065
+7,056
+78,400% +$558K ﹤0.01% 1272
2016
Q1
$1K Hold
9
﹤0.01% 2029
2015
Q4
$1K Buy
+9
New +$1.45K ﹤0.01% 2019

Other funds holding LRMR